Zobrazeno 1 - 10
of 188
pro vyhledávání: '"Hideki Kasuya"'
Autor:
Patricia Angela Sibal, Shigeru Matsumura, Toru Ichinose, Itzel Bustos‐Villalobos, Daishi Morimoto, Ibrahim R. Eissa, Mohamed Abdelmoneim, Mona Alhussein Mostafa Aboalela, Nobuaki Mukoyama, Maki Tanaka, Yoshinori Naoe, Hideki Kasuya
Publikováno v:
Molecular Oncology, Vol 18, Iss 5, Pp 1259-1277 (2024)
Oncolytic viruses (OVs) can selectively replicate in tumor cells and remodel the microenvironment of immunologically cold tumors, making them a promising strategy to evoke antitumor immunity. Similarly, agonists of the stimulator of interferon genes
Externí odkaz:
https://doaj.org/article/c189155387224a828e2869d71171198a
Autor:
Mohamed Abdelmoneim, Ibrahim Ragab Eissa, Mona Alhussein Aboalela, Yoshinori Naoe, Shigeru Matsumura, Patricia Angela Sibal, Itzel Bustos-Villalobos, Maki Tanaka, Yasuhiro Kodera, Hideki Kasuya
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Oncolytic virus (OV) therapy is a promising cancer immunotherapy, especially for cold tumors by inducing the direct lysis of cancer cells and initiation of potent antitumor response. Canerpaturev (C-REV) is an attenuated oncolytic herpes sim
Externí odkaz:
https://doaj.org/article/c1af3202992a44e695757064bacf6038
Autor:
Mohamed Abdelmoneim, Mona Alhussein Aboalela, Yoshinori Naoe, Shigeru Matsumura, Ibrahim Ragab Eissa, Itzel Bustos-Villalobos, Patricia Angela Sibal, Yuhei Takido, Yasuhiro Kodera, Hideki Kasuya
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 17, p 13353 (2023)
The tumor microenvironment (TME) plays a pivotal role in the fate of cancer cells, and tumor-infiltrating immune cells have emerged as key players in shaping this complex milieu. Cancer is one of the leading causes of death in the world. The most com
Externí odkaz:
https://doaj.org/article/a241089eb76e4242bc7a83d61c46e5cc
Autor:
Zhiwen Wu, Toru Ichinose, Yoshinori Naoe, Shigeru Matsumura, Itzel Bustos Villalobos, Ibrahim Ragab Eissa, Suguru Yamada, Noriyuki Miyajima, Daishi Morimoto, Nobuaki Mukoyama, Yoko Nishikawa, Yusuke Koide, Yasuhiro Kodera, Maki Tanaka, Hideki Kasuya
Publikováno v:
Molecular Therapy: Oncolytics, Vol 13, Iss , Pp 107-115 (2019)
The naturally occurring oncolytic herpes simplex virus canerpaturev (C-REV), formerly HF10, proved its therapeutic efficacy and safety in multiple clinical trials against melanoma, pancreatic, breast, and head and neck cancers. Meanwhile, patients wi
Externí odkaz:
https://doaj.org/article/9b6f4da8ad6449de8a0f3b87ef1862cf
Autor:
Carmen Wong, Walter van den Broek, Gillian Doody, Martin Fischer, Michelle Leech, Fabrizio De Ponti, Alexander Gerbes, Hiroshi Nishigori, Young Mee Lee, Maarten Frens, Hideki Kasuya, Franco Bazzoli, Reinhard Hickel, Hong Sik Lee, J.P.T.M van Leeuwen, Christina Mitchell, Kenji Kadomatsu, John Atherton, Francis Chan
Publikováno v:
MedEdPublish, Vol 10, Iss 1 (2021)
Medical faculties have the responsibility to train tomorrow's doctors and in a crisis face the challenge of delivering students into the workforce promptly and safely. Worldwide, medical faculties have faced unprecedented disruptions from viral outbr
Externí odkaz:
https://doaj.org/article/01fd82e2093d49558b51b83f6bb678a3
Autor:
Yoshiki Hirooka, Hideki Kasuya, Takuya Ishikawa, Hiroki Kawashima, Eizaburo Ohno, Itzel B. Villalobos, Yoshinori Naoe, Toru Ichinose, Nobuto Koyama, Maki Tanaka, Yasuhiro Kodera, Hidemi Goto
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Prognosis of pancreatic cancer is poor with a 5-year survival rate of only 7%. Although several new chemotherapy treatments have shown promising results, all patients will eventually progress, and we need to develop newer chemothe
Externí odkaz:
https://doaj.org/article/d2a2d0e1825f4203b4675bd4b2eba05b
Autor:
Daishi Morimoto, Shigeru Matsumura, Itzel Bustos-Villalobos, Patricia Angela Sibal, Toru Ichinose, Yoshinori Naoe, Ibrahim Ragab Eissa, Mohamed Abdelmoneim, Nobuaki Mukoyama, Noriyuki Miyajima, Maki Tanaka, Yasuhiro Kodera, Hideki Kasuya
Publikováno v:
Cells, Vol 10, Iss 6, p 1502 (2021)
Oncolytic virus (OV) therapy is widely considered as a major breakthrough in anti-cancer treatments. In our previous study, the efficacy and safety of using C-REV for anti-cancer therapy in patients during stage I clinical trial was reported. The sti
Externí odkaz:
https://doaj.org/article/dd38fa8a2e174e95a0014579daa73dc1
Autor:
Ibrahim Ragab Eissa, Yoshinori Naoe, Itzel Bustos-Villalobos, Toru Ichinose, Maki Tanaka, Wu Zhiwen, Nobuaki Mukoyama, Taishi Morimoto, Noriyuki Miyajima, Hasegawa Hitoki, Seiji Sumigama, Branko Aleksic, Yasuhiro Kodera, Hideki Kasuya
Publikováno v:
Frontiers in Oncology, Vol 7 (2017)
Oncolytic viruses (OVs) are opening new possibilities in cancer therapy with their unique mechanism of selective replication within tumor cells and triggering of antitumor immune responses. HF10 is an oncolytic herpes simplex virus-1 with a unique ge
Externí odkaz:
https://doaj.org/article/dfaa583e56c8449589481c0b863f5f2b
Autor:
Mohammad Abul Bashar Sarker, Mahbubur Rahman, Md Harun-Or-Rashid, Shaila Hossain, Hideki Kasuya, Junichi Sakamoto, Nobuyuki Hamajima
Publikováno v:
Tobacco Induced Diseases, Vol 11, Iss July (2013)
Background Several studies in the past have reported inconclusive evidences on association of smoking and migraine. Nevertheless, no study so far reported association of smokeless tobacco with migraine. The objective of this study was to examine the
Externí odkaz:
https://doaj.org/article/5f2c5e2ee7764fc7b294627d8aa5c918
Autor:
Junko Iwatsuki, Hideki Kasuya, Nobutaro Ban, Norbert Skokauskas, Hideki Takami, Tetsuya Yagi, Takeshi Kondo, Noriyuki Takahashi, Branko Aleksic, Hiroshi Nishigori, Itzel Bustos-Villalobos
Publikováno v:
Advances in Medical Education and Practice
Junko Iwatsuki,1,2 Takeshi Kondo,3 Noriyuki Takahashi,3â 5 Hideki Takami,3 Hiroshi Nishigori,6 Itzel Bustos-Villalobos,7 Branko Aleksic,7,8 Hideki Kasuya,7 Nobutaro Ban,9 Tetsuya Yagi,10 Norbert Skokauskas11,12 1International Collaboration Plann